Linagliptin provides effective, well-tolerated add-on therapy to pre-existing oral antidiabetic therapy over 1 year in Japanese patients with type 2 diabetes

✍ Scribed by Inagaki, N.; Watada, H.; Murai, M.; Kagimura, T.; Gong, Y.; Patel, S.; Woerle, H.-J.

• Book ID: 121268987
• Publisher: John Wiley and Sons
• Year: 2013
• Tongue: English
• Weight: 594 KB
• Volume: 15
• Category: Article
• ISSN: 1462-8902
• DOI: 10.1111/dom.12110